Literature DB >> 4448408

Identifying toxic fractions of wheat gluten and their effect on the jejunal mucosa in coeliac disease.

A S Dissanayake, D W Jerrome, R E Offord, S C Truelove, R Whitehead.   

Abstract

THE TOXICITY OF THREE FRACTIONS (A, B, AND C) OBTAINED BY ULTRAFILTRATION OF A PEPTIC: tryptic digest of gluten has been assessed by serial feeding experiments in patients with treated coeliac disease. The first fraction (A), which contains amino acids and oligopeptides, produced no damage to the jejunal mucosa. The other two fractions (B and C) both caused mucosal damage. Fraction B, which contains the products of digestion of smaller molecular weight, consists of polypeptides which are concentrated in the region of 8000 molecular weight. It contains no gliadin (molecular weight 50 000) or gluten. Ultrastructural evidence of damage was visible six hours after challenge with fraction B and by 10 hours histological abnormalities were also present. Ultrastructural abnormalities occurred early in the epithelial cells and preceded changes in the basement membrane and capillaries. The disaccharidases showed a pronounced depression in all three subjects by 24 hours. The rapid onset of damage after challenge, coupled with the evidence of recovery as soon as 72 hours later, is more in keeping with a direct action on the surface epithelial cells rather than an immune mechanism.

Entities:  

Mesh:

Substances:

Year:  1974        PMID: 4448408      PMCID: PMC1413069          DOI: 10.1136/gut.15.12.931

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  21 in total

1.  [Further investigations on the toxic effect of wheat flour in celiac disease. 2. Effect of enzymatic by-products of gliadin].

Authors:  H G KRAINICK; G MOHN
Journal:  Helv Paediatr Acta       Date:  1959-06

2.  HEREDITARY SUCROSE INTOLERANCE: LEVELS OF SUCRASE ACTIVITY IN JEJUNAL MUCOSA.

Authors:  E A BURGESS; B LEVIN; D MAHALANABIS; R E TONGE
Journal:  Arch Dis Child       Date:  1964-10       Impact factor: 3.791

3.  CROSBY SMALL-INTESTINAL CAPSULE WITH RADIO-OPAQUE TUBE AND LATEX SHEATH.

Authors:  S N SALEM; R H SALT; S C TRUELOVE
Journal:  Gut       Date:  1965-02       Impact factor: 23.059

4.  Gluten-induced enteropathy: the effect of partially digested gluten.

Authors:  A C FRAZER; R F FLETCHER; C A ROSS; B SHAW; H G SAMMONS; R SCHNEIDER
Journal:  Lancet       Date:  1959-09-05       Impact factor: 79.321

5.  The pathogenesis of shigella diarrhea. II. Enterotoxin-induced acute enteritis in the rabbit ileum.

Authors:  G T Keusch; G F Grady; A Takeuchi; H Sprinz
Journal:  J Infect Dis       Date:  1972-07       Impact factor: 5.226

6.  Toxicity of wheat gliadin fractions in coeliac disease.

Authors:  R R Townley; H J Cornell; P S Bhathal; J D Mitchell
Journal:  Lancet       Date:  1973-06-16       Impact factor: 79.321

7.  Gluten subfractions in coeliac disease.

Authors:  M J Kendall; R Schneider; P S Cox; C F Hawkins
Journal:  Lancet       Date:  1972-11-18       Impact factor: 79.321

8.  Enzymatic digestion of gliadin: the effect of the resultant peptides in adult celiac disease.

Authors:  H D Bronstein; L J Haeffner; O D Kowlessar
Journal:  Clin Chim Acta       Date:  1966-08       Impact factor: 3.786

9.  Coeliac disease. IV. An investigation into the injurious constituents of wheat in connection with their action on patients with coeliac disease.

Authors:  J H VAN DE KAMER; H A WEIJERS; W K DICKE
Journal:  Acta Paediatr       Date:  1953-05       Impact factor: 2.299

10.  Ultrastructural changes suggestive of immune reactions in the jejunal mucosa of coeliac children following gluten challenge.

Authors:  M Shiner
Journal:  Gut       Date:  1973-01       Impact factor: 23.059

View more
  12 in total

1.  Macrophage procoagulant activity as an assay of cellular hypersensitivity to gluten peptides in coeliac disease.

Authors:  J M Devery; C L Geczy; D DeClarle; J H Skerritt; S A Krillis
Journal:  Clin Exp Immunol       Date:  1990-11       Impact factor: 4.330

Review 2.  The immunology of coeliac disease.

Authors:  G J Mantzaris; W M Rosenberg; D P Jewell
Journal:  Springer Semin Immunopathol       Date:  1990

Review 3.  Cereal chemistry, molecular biology, and toxicity in coeliac disease.

Authors:  R P Sturgess; H J Ellis; P J Ciclitira
Journal:  Gut       Date:  1991-09       Impact factor: 23.059

Review 4.  Investigation of cereal toxicity in coeliac disease.

Authors:  P J Ciclitira; H J Ellis
Journal:  Postgrad Med J       Date:  1987-09       Impact factor: 2.401

5.  Specificity of leucocyte migration inhibition test in coeliac disease. A reassessment using different gluten subfractions.

Authors:  G R Corazza; P M Rawcliffe; M Frisoni; P Sarchielli; M Londei; M Campieri; R Lazzari; G Gasbarrini
Journal:  Clin Exp Immunol       Date:  1985-04       Impact factor: 4.330

6.  Acute gluten challenge in treated adult coeliac disease: a morphometric and enzymatic study.

Authors:  M G Bramble; S Zucoloto; N A Wright; C O Record
Journal:  Gut       Date:  1985-02       Impact factor: 23.059

7.  Does the reticulin binding property of cereal proteins demonstrable in vitro have pathogenetic significance for coeliac disease?

Authors:  D J Unsworth; E J Holborow
Journal:  Gut       Date:  1985-11       Impact factor: 23.059

8.  Symptomatic suspected gluten exposure is common among patients with coeliac disease on a gluten-free diet.

Authors:  J A Silvester; L A Graff; L Rigaux; J R Walker; D R Duerksen
Journal:  Aliment Pharmacol Ther       Date:  2016-07-22       Impact factor: 8.171

9.  Anti-gliadin antibody specificity for gluten-derived peptides toxic to coeliac patients.

Authors:  J M Devery; J T La Brooy; S Krillis; G Davidson; J H Skerritt
Journal:  Clin Exp Immunol       Date:  1989-06       Impact factor: 4.330

10.  Cellular hypersensitivity to gluten derived peptides in coeliac disease.

Authors:  R Guan; P M Rawcliffe; J D Priddle; D P Jewell
Journal:  Gut       Date:  1987-04       Impact factor: 23.059

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.